Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy

Coylewright, Megan

doi:10.1001/jamacardio.2023.1459

Cited by 1 publication

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An optimal "shared decision-making" process should involve a comprehensive discussion with the patient, considering evidence-based information on available options, the provider's expertise, and the patient's values and preferences. Each method's significant limitations or knowledge gaps must be fully disclosed to the patient to avoid limited engagement and a lack of understanding, which may eventually lead to distrust [4]. This editorial addresses critical, relevant questions frequently asked by patients and debated among cardiovascular providers.…”

Section: Introductionmentioning

confidence: 99%

Bioprosthetic Valves for Lifetime Management of Aortic Stenosis: Pearls and Pitfalls

Mylonas,

Angouras

2023

JCM

View full text Add to dashboard Cite

This review explores the use of bioprosthetic valves for the lifetime management of patients with aortic stenosis, considering recent advancements in surgical (SAV) and transcatheter bioprostheses (TAV). We examine the strengths and challenges of each approach and their long-term implications. We highlight differences among surgical bioprostheses regarding durability and consider novel surgical valves such as the Inspiris Resilia, Intuity rapid deployment, and Perceval sutureless bioprostheses. The impact of hemodynamics on the performance and durability of these prostheses is discussed, as well as the benefits and considerations of aortic root enlargement during Surgical Aortic Valve Replacement (SAVR). Alternative surgical methods like the Ross procedure and the Ozaki technique are also considered. Addressing bioprosthesis failure, we compare TAV-in-SAV with redo SAVR. Challenges with TAVR, such as TAV explantation and considerations for coronary circulation, are outlined. Finally, we explore the potential challenges and limitations of several clinical strategies, including the TAVR-first approach, in the context of aortic stenosis lifetime management. This concise review provides a snapshot of the current landscape in aortic bioprostheses for physicians and surgeons.

show abstract

Section: Introductionmentioning

confidence: 99%

Bioprosthetic Valves for Lifetime Management of Aortic Stenosis: Pearls and Pitfalls

Mylonas,

Angouras

2023

JCM

View full text Add to dashboard Cite

show abstract

Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy

Abstract: This Viewpoint describes how shared decision-making should be used in patients with aortic stenosis who have a longer life expectancy.

Cited by 1 publication

References 11 publications

Bioprosthetic Valves for Lifetime Management of Aortic Stenosis: Pearls and Pitfalls

Bioprosthetic Valves for Lifetime Management of Aortic Stenosis: Pearls and Pitfalls

Contact Info

Product

Resources

About